Relay Therapeutics, Inc. Common Stock
RLAYNASDAQHealthcare · Biological Products, (no Diagnostic Substances)
Market cap
$3.14B
Employees
192
Exchange
NASDAQ
Headquarters
CAMBRIDGE, MA
About Relay Therapeutics, Inc. Common Stock
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Industry
Biological Products, (no Diagnostic Substances)
Sector
Healthcare
Country
US
Website
www.relaytx.com